Factor analyzed | p-value |
---|---|
Development of side effects | 0.596 |
Gender | 0.729 |
Age (>/= vs. <58 years) | 0.314 |
Clark level (>/= vs. < CL III) | 0.786 |
Tumor thickness (>/= vs. < TT 2.25 mm) | 0.646 |
Extra-cerebral metastases | 0.206 |
RPA class | <0.001 |
DS-GPA-score | <0.001 |
Surgical resection of BM | 0.01 |
Total treatment dose (30 vs. 40 Gy) | 0.003 |